Citadel Advisors »

Adial Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 33k 1.00
2024-06-30 $29k 25k 1.15

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Adial Pharmaceuticals

Manchester Capital Management
Geode Capital Management
Citadel Advisors
BlackRock
BlackRock
Tower Research Capital
1620 Investment Advisors
Bank of America Corporation
Benjamin F. Edwards & Company
Morgan Stanley
Abound Wealth Management
Qube Research & Technologies

View all funds holding Adial Pharmaceuticals